- Home
- IPHA vs ITRG Comparison
IPHA vs ITRG Comparison
Compare IPHA & ITRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- ITRG
- Stock Information
- Founded
- IPHA 1999
- ITRG 1997
- Country
- IPHA France
- ITRG Canada
- Employees
- IPHA N/A
- ITRG N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- ITRG Precious Metals
- Sector
- IPHA Health Care
- ITRG Basic Materials
- Exchange
- IPHA Nasdaq
- ITRG Nasdaq
- Market Cap
- IPHA 160.1M
- ITRG 178.7M
- IPO Year
- IPHA 2019
- ITRG N/A
- Fundamental
- Price
- IPHA $1.98
- ITRG $1.24
- Analyst Decision
- IPHA Strong Buy
- ITRG Strong Buy
- Analyst Count
- IPHA 1
- ITRG 1
- Target Price
- IPHA $11.50
- ITRG $2.75
- AVG Volume (30 Days)
- IPHA 16.2K
- ITRG 461.9K
- Earning Date
- IPHA 03-27-2025
- ITRG 03-26-2025
- Dividend Yield
- IPHA N/A
- ITRG N/A
- EPS Growth
- IPHA N/A
- ITRG N/A
- EPS
- IPHA N/A
- ITRG N/A
- Revenue
- IPHA $20,831,349.00
- ITRG $30,350,000.00
- Revenue This Year
- IPHA $220.44
- ITRG $490.21
- Revenue Next Year
- IPHA $81.85
- ITRG $37.03
- P/E Ratio
- IPHA N/A
- ITRG N/A
- Revenue Growth
- IPHA N/A
- ITRG N/A
- 52 Week Low
- IPHA $1.29
- ITRG $0.70
- 52 Week High
- IPHA $3.51
- ITRG $1.38
- Technical
- Relative Strength Index (RSI)
- IPHA 48.63
- ITRG 53.27
- Support Level
- IPHA $1.77
- ITRG $1.18
- Resistance Level
- IPHA $2.03
- ITRG $1.13
- Average True Range (ATR)
- IPHA 0.08
- ITRG 0.09
- MACD
- IPHA -0.01
- ITRG 0.00
- Stochastic Oscillator
- IPHA 65.63
- ITRG 56.06
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of highly prospective early-stage exploration projects in Idaho, Nevada, and Arizona.